- Home
- EDSA vs MDAI Comparison
EDSA vs MDAI Comparison
Compare EDSA & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDSA | MDAI |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 48.0M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EDSA | MDAI |
|---|---|---|
| Price | $2.22 | $1.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.33 | $5.11 |
| AVG Volume (30 Days) | ★ 2.9M | 126.8K |
| Earning Date | 12-11-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.88 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $19,650,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $74.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $1.18 |
| 52 Week High | $20.32 | $2.97 |
Technical Indicators
Market Signals| Indicator | EDSA | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 35.10 | 40.32 |
| Support Level | $0.83 | $1.18 |
| Resistance Level | $4.27 | $1.67 |
| Average True Range (ATR) | 0.34 | 0.09 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 14.90 | 45.19 |
Price Performance
Historical ComparisonAbout EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.